Monthly Archives: September 2015

Avycaz (ceftazidime and avibactam): Drug Safety Communication – Dose Confusion and Medication Errors

Audience: Infectious Disease, Pharmacy ISSUE: FDA is warning health care professionals about the risk for dosing errors with the intravenous antibacterial drug Avycaz (ceftazidime and avibactam) due to confusion about the drug strength displayed on...

Read More »

Tramadol: Drug Safety Communication – FDA Evaluating Risks of Using in Children Aged 17 and Younger

Audience: Health Professionals ISSUE:  FDA is investigating the use of the pain medicine tramadol in children aged 17 years and younger, because of the rare but serious risk of slowed or difficult breathing. This risk may be increased in children...

Read More »